10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols

Retinal Laser Therapy and Laser Safety

Retinal laser systems can deliver enough optical energy to injure retina, cornea, skin, or staff eyes. Safe assisting combines clinical verification with a formal laser-safety program. The technician does not choose treatment spots, power, duration, or endpoint unless a lawful, delegated protocol explicitly assigns a technical control.

Common treatment concepts

Panretinal photocoagulation (PRP) places burns in peripheral ischemic retina to reduce angiogenic drive in selected proliferative retinopathies. Focal or grid treatment may target defined leakage patterns in selected conditions. Retinopexy creates chorioretinal adhesion around a break. Photodynamic therapy (PDT) activates verteporfin with a specified nonthermal wavelength in selected choroidal disorders.

Each procedure has different indications, optics, contact lenses, parameters, and risks. Do not describe every laser as sealing a leak or directly destroying new vessels. The clinician selects treatment from the diagnosis and current evidence.

Controlled-area preparation

Before use:

1. verify service and self-test status, key control, emergency stop, footswitch, delivery fiber, slit-lamp coupling, filters, and warning light;
2. restrict access and display the required warning sign;
3. remove reflective jewelry or instruments when relevant and manage flammable material;
4. provide wavelength-specific eyewear for everyone who requires it;
5. confirm smoke evacuation or plume control when the procedure generates plume;
6. prepare the correct contact lens, coupling agent, and sterile supplies.

Protective eyewear is not selected by color or a generic OD 5 label. The laser safety officer or approved chart determines the wavelength range and optical density from the system output and exposure analysis. Eyewear for a 532 nm laser may not protect against an 810 nm system.

Time-out and treatment support

Use two identifiers and confirm the eye, planned procedure, laser, wavelength, delivery system, consent status, and treatment plan. Position the patient and explain fixation without promising a painless or complication-free procedure. Maintain stable contact-lens coupling and promptly report loss of view, corneal drying, patient movement, equipment alarms, or an unexpected tissue effect.

Only the treating clinician changes power, spot size, duration, pattern, or endpoint unless the documented delegation and policy state otherwise. Record the parameters reported by the laser system and practitioner; do not reconstruct them from memory.

Laser hazards

Direct, reflected, or scattered radiation can injure tissue. The risk depends on wavelength, power, pulse duration, beam geometry, distance, and exposure. Nonbeam hazards include electrical energy, fire, compressed gas, trip hazards, plume, and medication reactions. Keep the emergency stop accessible and never bypass an interlock or warning.

If a wrong-eye concern, unexpected burn, smoke, fire, eyewear failure, or system fault occurs, stop delivery, keep the patient safe, and notify the responsible clinician and laser safety officer.

Verteporfin counseling

The current U.S. VISUDYNE prescribing information warns that patients are photosensitive after infusion. For five days, they should avoid direct sunlight and bright indoor light such as tanning salons, bright halogen lighting, and high-power surgical or dental lights. If daylight exposure is unavoidable, protect skin and eyes with clothing and dark sunglasses; ultraviolet sunscreen alone is not sufficient because visible light can activate residual drug.

Patients should not remain in darkness. Ordinary indoor ambient light helps photobleach the drug. Prolonged exposure to light-emitting medical devices on the skin should also be avoided during the labeled interval. Give the current manufacturer handout because labeling can change.

Post-procedure documentation

Record patient, eye, laser and wavelength, lens, delivered settings and counts as reported, personnel, complications, and instructions. Reinforce clinician-approved warning signs and follow-up. PRP may reduce peripheral field or night vision and may worsen macular edema; retinopexy does not guarantee that detachment cannot occur. New symptoms are escalated promptly.

The exam principle is that laser safety is engineered and wavelength-specific, while treatment decisions remain clinician-directed.

Room control and post-procedure handoff

Control entry while the laser is enabled, display the required warning, minimize reflective items, and keep the key or enable control with authorized staff. Confirm that the delivery lens, filters, microscope, fiber, foot pedal, plume control when applicable, and emergency stop match the system. Everyone in the nominal hazard zone uses protection selected for the operating wavelength and exposure; ordinary sunglasses and generic "laser glasses" are not substitutes.

Record the device, wavelength, treated eye, operator, delivered settings and counts as required, protective measures, complications, and any aborted portion. The clinician supplies the diagnosis and treatment interpretation. After photodynamic therapy with verteporfin, give the current product-specific light precautions exactly as written and confirm understanding; do not shorten the labeled interval from memory. Route severe pain, sudden vision change, neurologic symptoms, or an equipment-related event through the emergency and incident-reporting processes.